Lawsuits Question Safety of GLP-1 Agonists Amid Unclear Frequency of Harms | Retatrutide News

Ongoing lawsuits allege serious harm from GLP-1 agonists, but the frequency of such events is unclear. This could affect the development and regulatory ...
Market News · October 10, 2026